WO/2016/146960 A MODULAR UNIVERSAL JOINT WITH HARMONISED CONTROL METHOD FOR AN ASSISTIVE EXOSKELETON||WO||22.09.2016|
||PCT/GB2015/050814||PHASEX AB||VIRK, Gurvinder Singh|
There is described a modular universal mechanism, system and method able to provide physical assistance at user upper- and lower-body joint as needed to the wearer by means being able to be configured to meet the individual needs. The design provides assistive non-medical exoskeletons to be realised and operated via a new type of controller; this control strategy is referred to as the "Harmonised controller" which is capable of providing the physical assistance in a comfortable and natural way, where the physical assistance is automatically adjusted to supplement the power provided by the user so that required activity can be performed without causing fatigue in the user. The exoskeleton, provides physical assistance to supplement the muscle effort of elderly persons and can also reduce/increase the muscle effort for a normal fully active person. The mechanism and controller are scalable and reusable.
WO/2016/146959 DEW POINT AND CARRY-OVER MONITORING||WO||22.09.2016|
||PCT/GB2015/050774||STATOIL PETROLEUM AS||DUPUY, Pablo Matias|
The invention relates to a method for automatically monitoring the liquid content in a gas, and in particular the gas leaving a scrubber and entering a compressor. In the method, a sample of fluid is taken from the outlet of the compressor, its temperature and pressure are automatically varied, and the pressure and temperature at which condensation forms is automatically detected. The pressure and temperature thus detected can be used to determine the liquid content in the gas. In a variant method, the temperature and pressure of the sample are automatically varied, and the rate of liquid condensation is measured to determine the liquid content.
WO/2016/147009 DREDGING APPARATUS AND METHOD OF DREDGING||WO||22.09.2016|
||PCT/GB2016/050767||WORMALD, Daniel J.||WORMALD, Daniel J.|
A dredging head assembly (12) for deploying on the bed (6) of a body of water (2), is provided, the assembly comprising a cutter housing (104) having a cutting opening (122) for extending over a section of the bed from which material is to be removed; a cutting assembly (130a) disposed within the cutter housing, the cutting assembly operable through the cutting opening in the cutter housing to loosen material from the bed; and an outlet opening (148) in the cutter housing for removing water and entrained material from within the cutter housing under suction; wherein the cutter housing comprises a plurality of holes (140;240) therein, in use water being drawn into the cutter housing through the holes under the action of reduced fluid pressure within the cutter housing. A dredging assembly (10) comprising the dredging head assembly (12) and a method of dredging are also provided.
WO/2016/147010 FASTENER ASSEMBLY||WO||22.09.2016|
||PCT/GB2016/050769||THE BRACKET COMPANY LTD||DAVIDSON, James Anthony|
This fastener assembly includes a body, an elongated member and a split wedge. The body defines a cavity that converges. An access opening at a small end provides access to the cavity. The member has a circumferential external profile at one end. The split wedge has two or more wedge segments with a flexible hinge connecting each of the wedge segments. Each of the wedge segments has an internal profile. The member is inserted through the access opening into the cavity of the body, the wedge segments of the split wedge are positioned circumferentially around the member and then the split wedge is wedged in the cavity to maintain the external profile of the member engaged with the internal profile of the wedge segments of the split wedge.
WO/2016/147011 SPIROCYCLIC COMPOUNDS AS AGONISTS OF THE MUSCARINIC M1 RECEPTOR AND/OR M4 RECEPTOR||WO||22.09.2016|
||PCT/GB2016/050771||HEPTARES THERAPEUTICS LIMITED||CONGREVE, Miles Stuart|
This invention relates to compounds that are agonists of the muscarinic M1 and/or M4 receptor and which are useful in the treatment of muscarinic M1/M4 receptor mediated diseases. Also provided are pharmaceutical compositions containing the compounds and the therapeutic uses of the compounds. Compounds provided are of formula. (I) where p, q, r, s, X, Z, Y, R1, R2, R3and R4 are as defined herein.
WO/2016/147013 BACK SUBSTRATE FOR AN OPTO-ELECTRONIC DEVICE MODULE AND A MODULE OF OPTO-ELECTRONIC DEVICES COMPRISING SAID BACK SUBSTRATE||WO||22.09.2016|
||PCT/GB2016/050781||CPI INNOVATION SERVICES LTD||WIJDEKOP, Maarten|
The present invention relates to a back substrate for an opto-electronic device module, the back substrate comprising on a surface thereof a plurality of opto-electronic devices, said opto-electronic devices comprising a photo-anode and a cathode, wherein the back substrate additionally comprises a pattern of conductors, which in use; (i) collect current from the photo-anode, (ii) collect current from the cathode, and (iii) provide an electrical interconnection between the photo-anode of an opto-electronic device and the cathode of an adjacent opto-electronic device.
WO/2016/146979 ANTIBODIES AGAINST MODIFIED INSULIN FOR USE IN TREATMENT OF AND ASSAYS FOR DIABETES||WO||22.09.2016|
||PCT/GB2016/050678||QUEEN MARY UNIVERSITY OF LONDON||NISSIM, Ahuva|
The present invention provides a method of diagnosing type 1 diabetes (T1D) or latent autoimmune diabetes in adults (LADA) in a subject comprising testing a sample from the subject for the presence or absence of antibodies against modified insulin, wherein the presence of antibodies against modified insulin in the sample is indicative of T1D or LADA in the subject. The invention also provides a method of treating T1D or LADA in a subject in need thereof. Also provided are methods of determining the10 therapeutic effectiveness of a therapeutic agent in treating T1D or LADA in a subject diagnosed with T1D or LADA. A kit for diagnosing T1D or LADA in a subject comprising reagents for determining the presence of antibodies against modified insulin in a sample from a subject is also provided.
WO/2016/146981 NOVEL FORMULATIONS||WO||22.09.2016|
||PCT/GB2016/050682||KING'S COLLEGE LONDON||STRANG, John|
A solid formulation comprising an antagonist of an opiate or opioid substance, such as naloxone or a salt or hydrate of said antagonist, in the absence of any opiate or opioid agonist, suitable for buccal administration, for use in the treatment of an opiate or opioid overdose. Novel formulations including in particular instant disintegrating tablets (IDTs) are also described and claimed.
WO/2016/146962 IMPROVEMENTS IN AND RELATING TO A FISHING DREDGE||WO||22.09.2016|
||PCT/GB2016/000048||DEESIDE MARINE LIMITED||GIDNEY, Richard|
A fishing dredge (101) for making a catch of molluscs such as scallops. The fishing dredge has a dredge frame (104) with rotatable sea bed engaging members (105) arranged along the length of the sides of the dredge frame, a catch tray (103) for collecting an unearthed catch which is positioned in the dredge frame between the rotatable sea bed engaging members and sea bed engaging teeth (141) mounted on the dredge frame, the teeth being positioned at or near the front of the dredge frame for unearthing objects buried in the sea bed. The dredge frame is also fitted with a sorting mechanism (127) positioned between the sea bed engaging teeth (141) and the catch tray (103) for separating the catch from other unearthed objects and for moving the catch into the catch tray.
WO/2016/146968 PCR METHOD||WO||22.09.2016|
||PCT/GB2016/050558||SALISBURY NHS FOUNDATION TRUST||WARD, Daniel Leonard|
A method for generating amplicon constructs of a target sequence is disclosed, the method comprising providing a target sequence; an oligonucleotide probe, comprising a universal sequence and further comprising, at or towards its 5' end, a target specific sequence capable of hybridising to the reverse complement of a sequence at, or flanking one of the 3' ends of the target sequence; a universal primer, comprising at its 3' end a sequence capable of hybridising to the universal sequence of the oligonucleotide probe and performing a Polymerase Chain Reaction (PCR).